title: Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil.
authors.forename: Ridvan
authors.initials: R
authors.lastname: Ali
authors.forename: Fahir
authors.initials: F
authors.lastname: Ozkalemkas
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Kimya
authors.forename: Nilgun
authors.initials: N
authors.lastname: Koksal
authors.forename: Vildan
authors.initials: V
authors.lastname: Ozkocaman
authors.forename: Hakan
authors.initials: H
authors.lastname: Yorulmaz
authors.forename: Ayca
authors.initials: A
authors.lastname: Eroglu
authors.forename: Tulay
authors.initials: T
authors.lastname: Ozcelik
authors.forename: Ahmet
authors.initials: A
authors.lastname: Tunali
mesh_terms: D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002699:Chlorambucil / Q000009:adverse effects*; D005260:Female; D005333:Fetus; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D011225:Pre-Eclampsia; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D011297:Prenatal Exposure Delayed Effects
chemical_list: D000963:Antimetabolites; D018906:Antineoplastic Agents, Alkylating; D002699:Chlorambucil; D000493:Allopurinol